Winnie Yeo
Impact in
- Hepatology top 0.05%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Liver Disease and Transplantation
- Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies
Papers in
- Oncology 107
- Cancer survivorship and care 16
- Pancreatic and Hepatic Oncology Research 16
- Cancer Immunotherapy and Biomarkers 15
- Hepatology 92
- Hepatocellular Carcinoma Treatment and Prognosis 76
- Hepatitis C virus research 18
- Co-authors
- Philip J. Johnson (69 shared papers)Frankie Mo (85 shared papers)Tony Mok (66 shared papers)Stephen L. Chan (58 shared papers)Anthony T.�C. Chan (81 shared papers)Wing Ming Ho (24 shared papers)Paul B.S. Lai (34 shared papers)Paul K.S. Chan (20 shared papers)
- Journals
- Journal of Clinical Oncology (45 papers)Annals of Oncology (14 papers)Journal of Medical Virology (9 papers)Journal of Gastroenterology and Hepatology (8 papers)Cancer (8 papers)
- Partner nations
- Hong KongChinaUnited Kingdom
In The Last Decade
Winnie Yeo
287 papers receiving 13.5k citations
Winnie Yeo's Hit Papers
Peers
Comparison fields: 5 of 141
- Hepatology 5.5k
- Otorhinolaryngology 751
- Epidemiology 4.2k
- Oncology 2.8k
- Cancer Research 1.1k
Countries citing papers authored by Winnie Yeo
This map shows the geographic impact of Winnie Yeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Winnie Yeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Winnie Yeo more than expected).
Fields of papers citing papers by Winnie Yeo
This network shows the impact of papers produced by Winnie Yeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Winnie Yeo. The network helps show where Winnie Yeo may publish in the future.
Co-authors
The 25 scholars most cited alongside Winnie Yeo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 293 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade Hit paper breakdown → | 2014 | 1837 |
| 2 | 2000 | 496 | |
| 3 | Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab Hit paper breakdown → | 2008 | 477 |
| 4 | 2005 | 468 | |
| 5 | Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial Hit paper breakdown → | 2002 | 374 |
| 6 | 2010 | 373 | |
| 7 | 2006 | 369 | |
| 8 | 1999 | 293 | |
| 9 | 2004 | 253 | |
| 10 | 2008 | 243 | |
| 11 | 1995 | 222 | |
| 12 | Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. | 1999 | 217 |
| 13 | 2008 | 212 | |
| 14 | 2004 | 205 | |
| 15 | 2011 | 191 | |
| 16 | 2019 | 189 | |
| 17 | 2003 | 163 | |
| 18 | 2008 | 160 | |
| 19 | Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. | 2000 | 156 |
| 20 | 2015 | 154 |
About Winnie Yeo
Winnie Yeo is a scholar working on Oncology, Hepatology, Epidemiology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 293 papers that have together received 13.8k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (76 papers), Hepatitis B Virus Studies (30 papers), Liver Disease Diagnosis and Treatment (22 papers), Hepatitis C virus research (18 papers), Cancer survivorship and care (16 papers), Pancreatic and Hepatic Oncology Research (16 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Lung Cancer Treatments and Mutations (14 papers). The work is most often cited by research in Hepatology (5.5k citations), Otorhinolaryngology (751 citations), Epidemiology (4.2k citations), Oncology (2.8k citations) and Cancer Research (1.1k citations). Winnie Yeo has collaborated with scholars based in Hong Kong, China and United Kingdom. Frequent co-authors include Philip J. Johnson, Frankie Mo, Tony Mok, Stephen L. Chan, Anthony T.�C. Chan, Wing Ming Ho, Paul B.S. Lai, Paul K.S. Chan, Benny Zee and Sheng Zhong. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Medical Virology, Journal of Gastroenterology and Hepatology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.